Regulatory Focus: Bringing home the genome: the US FDA’s role in realizing personalized medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.7, Iss.3, 2010-05, pp. : 239-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

US FDA and personalized medicine: in vitro diagnostic regulatory perspective

By Težak Živana Kondratovich Marina V Mansfield Elizabeth

Personalized Medicine, Vol. 7, Iss. 5, 2010-09 ,pp. : 517-530

Future Medicine

Access to resources Recommend Favorite

Company Profile: N-of-One: realizing personalized medicine

By Carter Jennifer Levin Elkin Sheryl Barton Joan

Personalized Medicine, Vol. 8, Iss. 3, 2011-05 ,pp. : 311-315

Future Medicine

Access to resources Recommend Favorite

Regulatory and ethical challenges of personalized medicine

By Torr-Brown Sheryl R

Personalized Medicine, Vol. 7, Iss. 5, 2010-09 ,pp. : 465-468

Future Medicine

Access to resources Recommend Favorite

Bringing personalized medicine to the community through public engagement

By Etchegary Holly Wilson Brenda

Personalized Medicine, Vol. 10, Iss. 7, 2013-09 ,pp. : 647-659

Future Medicine

Access to resources Recommend Favorite

Role of proteomics in personalized medicine

By Geho David H Cooper James N Espina Virginia Garaci Enrico Petricoin 3rd Emanuel F Liotta Lance

Personalized Medicine, Vol. 3, Iss. 3, 2006-08 ,pp. : 223-226

Future Medicine

Access to resources Recommend Favorite